The arrival of the the medication vial represents a notable breakthrough in the approach to metabolic control . This innovative drug combines two distinct mechanisms – agonist of the GLP-1 receptor and inhibition of the DPP-4 enzyme – providing a unique method for tackling obesity . Early clinical findings suggest substantial effectiveness in f